Article
Promoter methylation status of multiple genes in uveal melanoma.
Investigative ophthalmology & visual science - 1 Oct 2007
Merhavi Efrat, Cohen Yoram, Avraham Bat Chen R, Frenkel Shahar, Chowers Itay, Pe'er Jacob, Goldenberg-Cohen Nitza
Abstract excerpt
PURPOSE: Aberrant promoter hypermethylation of CpG islands is thought to play an important role in the inactivation of tumor-suppressor genes (TSGs) in cancer. Studies of cutaneous melanoma have reported a high methylation rate for MGMT, DAPK, RAR-b2, and RASSF1A. In colon cancer, SOCS-1, IGF-2,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
